Oral controlled release dosage forms. II. Glassy polymers in hydrophilic matrices

被引：16
|
作者：
Veiga, F [1 ]
Salsa, T [1 ]
Pina, ME [1 ]
机构：
[1] Univ Coimbra, Fac Pharm, Lab Galen & Pharmaceut Technol, P-3049 Coimbra, Portugal
来源：
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY | 1998年 / 24卷 / 01期
关键词：
D O I：
10.3109/03639049809082346
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Part I of this article reported general considerations of oral controlled release dosage forms and the applications of cellulose ether polymers in hydrophilic matrices. Part II of this study describes the advantages and disadvantages of limited swelling hydrophilic matrices, their preparation, mechanism, and parameters affecting drug release from these systems.
引用
收藏
页码：1 / 9
页数：9
相关论文
共 50 条
  • [1] Oral controlled-release dosage forms .1. Cellulose ether polymers in hydrophilic matrices
    Salsa, T
    Veiga, F
    Pina, ME
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1997, 23 (09) : 929 - 938
  • [2] Solubility considerations and design of controlled release dosage forms.
    Venkatesh, GM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U572 - U572
  • [3] Calculation of the plasma drug level with oral controlled release dosage forms. Effect of the dose frequency
    Ouriemchi, EM
    Vergnaud, JM
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 127 (02) : 177 - 184
  • [4] ORAL CONTROLLED RELEASE DOSAGE FORMS IN PERSPECTIVE
    BOGENTOFT, C
    PHARMACY INTERNATIONAL, 1982, 3 (11): : 366 - 369
  • [5] ORAL CONTROLLED RELEASE DOSAGE FORMS - A REVIEW
    DEHAAN, P
    LERK, CF
    PHARMACEUTISCH WEEKBLAD-SCIENTIFIC EDITION, 1984, 6 (02) : 57 - 67
  • [6] NATURAL POLYMERS FOR ORAL MODIFIED RELEASE DOSAGE FORMS
    Pavli, M.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 44 : 27 - 28
  • [7] Controlled-release oral dosage forms containing nimodipine solid dispersion and hydrophilic carriers
    Lee, Hyo-Jung
    Kim, Ju-Young
    Park, Sung-Hoon
    Rhee, Yun-Seok
    Park, Chun-Woong
    Park, Eun-Seok
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2017, 37 : 28 - 37
  • [8] Advantages of soluble over stable polymers for oral dosage forms with controlled release.
    Ainaoui, K
    Vergnaud, JM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U880 - U880
  • [9] BIOAVAILABILITY OF VALSARTAN LIQUID ORAL DOSAGE FORMS.
    Sunkara, G.
    Bende, G.
    Mendonza, A.
    Solar-Yohay, S.
    Biswal, S.
    Neelakantham, S.
    Wagner, R.
    Calder, M.
    Smith, H.
    Zhang, Y.
    Jarugula, V.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S122 - S123
  • [10] RESEARCH AND DEVELOPMENT OF ORAL CONTROLLED RELEASE DOSAGE FORMS
    MOES, AJ
    JOURNAL DE PHARMACIE DE BELGIQUE, 1989, 44 (01) : 60 - 70
12345